#Sweden #Stockholm #EQT Foundation #CNS therapies #blood-brain barrier

EQT Foundation's New Science Grants Initiative

The EQT Foundation has recently announced an exciting opportunity aimed at revolutionizing the field of central nervous system (CNS) medicine. This initiative invites scientists worldwide to submit proposals for pioneering technologies designed to overcome the blood-brain barrier (BBB), a major hurdle in treating neurological disorders. The foundation seeks to award grants ranging from €25,000 to €100,000 to those developing high-impact, deeptech solutions with the potential to significantly advance CNS therapy delivery.

For many patients struggling with neurological conditions such as Alzheimer's disease, Parkinson's disease, and other serious disorders, the BBB poses a significant challenge, preventing effective medications from reaching the brain. This biological barrier not only blocks over 98% of small-molecule drugs but also nearly all large molecule therapeutics, resulting in a critical gap in treatment options for millions of individuals. The need for breakthroughs in this area has never been more pressing, as countless patients await innovative therapies that can transform their lives.

Understanding the Blood-Brain Barrier

The BBB acts as a protective shield for the brain, but it also hampers the delivery of crucial medications. The EQT Foundation's grant program aims to eliminate this bottleneck by supporting research that opens new pathways for drug delivery. Proposals that leverage novel delivery systems or modalities capable of safely and effectively crossing the BBB will be prioritized.

Innovative technologies such as engineered vectors, nanoparticles, and receptor-mediated transport systems are among the areas of interest. Researchers are encouraged to propose methodologies that ensure therapeutics can bypass the BBB with precision.

In addition to advanced delivery platforms, the foundation is also focused on funding projects that explore biological and molecular approaches to modulate the BBB. This includes the development of chemical permeabilizers, techniques to induce transient openings in the barrier, and even genetically driven solutions that can support drug transport with a strong focus on safety.

Furthermore, the program promotes investigation into CNS-targeted gene therapies and the development of large molecule delivery systems that demonstrate significant effectiveness in brain penetration. Collaborations that combine technical innovation with therapeutic implications stood out as critical factors in the selection process for these grants.

Nurturing Bold Innovations

Cilia Holmes Indahl, CEO of the EQT Foundation, emphasized the importance of addressing the challenges associated with the BBB, stating, "This barrier represents one of the greatest unsolved challenges in medicine, limiting our ability to treat millions of patients with serious neurological conditions." Through this grant initiative, the foundation aims to foster an environment where bold scientific ideas can thrive, creating opportunities for transformative advancements in CNS care.

Selected grantees won't just receive funding; they will also gain access to EQT's extensive global network, which includes technical experts and potential industry partners. This comprehensive support system is designed to bridge the transition from scientific discovery to meaningful, scalable impact in patient care.

The call for proposals is now open and will remain so until April 7, 2026. Interested researchers are encouraged to submit their proposals through the EQT Foundation's dedicated submission portal.

The Path Forward

By supporting projects that challenge the limits of science, the EQT Foundation is poised to expedite significant advancements in neuroscience. The overlap of deeptech innovations with practical therapeutic applications not only inspires researchers but also ignites hope for patients with currently untreatable neurological disorders. This groundbreaking initiative holds promise to unlock the brain, providing new treatments that could change the landscape of CNS medicine for years to come.

For more information on applying for the grants, please visit EQT Foundation's grant submission page.